TABLE 3.
post-LuTX outcomes.
TLVRS (n = 26) | CLVRS (n = 328) | p = | TELVR (n = 56) | CELVR (n = 270) | p = | |
---|---|---|---|---|---|---|
Surgical revision | 5 (19.2%) | 17.7% | 0.843 | 8 (14.3%) | 16.2% | 0.708 |
Successful weaning | 24 (96.0%) | 95.5% | 0.894 | 55 (98.2%) | 98.3% | 0.973 |
Days ventilated | 2 (0.5–23) | 2 (0.5–79) | 0.159 | 2 (0.5–19) | 2 (0.5–79) | 0.563 |
Post-OP ECMO | 4 (15.4%) | 3.8% | 0.006 | 1 (1.8%) | 6.4% | 0.179 |
Post-OP ECMO (days) | 7 (3–9) | 4 (2–10) | 0.078 | 2 (2–2) | 5 (2–10) | 0.250 |
Days on ICU | 7 (3–213) | 6 (2–152) | 0.149 | 6 (2–107) | 7 (2–152) | 0.127 |
Days to transfer to normal ward | 11 (5–213) | 10 (3–118) | 0.154 | 9 (2–107) | 9 (2–118) | 0.382 |
Days to dismissal from hospital | 35 (15–105) | 37 (9–152) | 0.717 | 42 (18–109) | 35 (8–152) | 0.158 |
Death before dismissal | 2 (7.7%) | 8.0% | 0.963 | 1 (1.8%) | 5.8% | 0.203 |
Control columns consist of weighted data; TLVRS, patients with previous LVRS; CLVRS, matched controls; TELVR, patients with previous ELVR; CELVR, matched controls; surgical revisions include all later surgical interventions on the chest and the lungs; ICU, intensive care unit. Significant p values are highlited in bold italic.